MAMarta Amorim

Marta Amorim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marta Amorim has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Amets Sagarribay

    Neurosurgery Unit, Unidade Local de Saúde São José, Lisbon, Portugal

    1 shared publication
  • Ana Isabel Cordeiro

    Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases. Hospital Dona Estefânia. Centro Hospitalar Universitário de Lisboa Central. Lisbon; Pediatric Neurology Department. Hospital Dona Estefânia. Centro Hospitalar Universitário de Lisboa Central. Lisbon

    1 shared publication
  • Andreia Pereira

    Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases. Hospital Dona Estefânia. Centro Hospitalar Universitário de Lisboa Central. Lisbon; Pediatric Neurology Department. Hospital Dona Estefânia. Centro Hospitalar Universitário de Lisboa Central. Lisbon

    1 shared publication
  • Catarina Limbert

    Hospital de Dona Estefânia, Unidade de Endocrinologia Pediátrica, CHULC/NOVA Medical School, 1169-045 Lisboa, Portugal

    1 shared publication
  • Filipa Briosa

    Department of Paediatrics, Hospital Beatriz Angelo, Loures, Portugal

    1 shared publication
  • Isabel Bretes

    Serviço de Pediatria, Hospital Nossa Senhora do Rosário, Unidade Local de Saúde Arco Ribeirinho

    1 shared publication

Latest Publications

  • Open Access

    Global Hypotonia, Areflexia and Severe Cognitive Impairment: A TECPR2-HSAN with Intellectual Disability Case Report

    by Maria Inês Neto, Mafalda Matias, Isabel Bretes, Marta Amorim, José Pedro Vieira, Susana Rocha

    TECPR2-related hereditary sensory and autonomic neuropathy with intellectual disability (TECPR2-HSAN with ID) is a rare and complex neurological disorder characterized by developmental delay, hypotonia, intellectual disability, ataxia, paraplegia and areflexia. Most patients experience autonomic dysfunction, central hypoventilation, and die before the third decade of life.We report the case of a seven-year-old boy with dysmorphic features, axial hypotonia from birth, and global developmental delay progressing to lower-limb areflexia, severe intellectual disability, dysarthria and ataxia. He experienced nocturnal apneas and episodes of dysphagia and choking, some associated with aspiration pneumonia and decreased alertness. Extensive investigations were inconclusive until exome sequencing at age 16 identified a homozygous variant in the TECPR2 gene, confirming the diagnosis.This case contributes to the limited literature on this rare disorder and highlights its progressive multisystem involvement and diagnostic challenges. Early exome sequencing can reduce diagnostic delay, guiding management, anticipatory care, and family counseling.

  • Open Access

    Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal

    by Mafalda Rebelo, Telma Francisco, Rosário Perry da Câmara, Andreia Pereira, Amets Iraneta, Marta Amorim, Maria João Paiva Lopes, Rita Lopes da Silva, Ana Isabel Cordeiro

    Introduction: Neurocutaneous syndromes (NCS) are a heterogeneous group of conditions with multiorgan involvement and diverse manifestations, evolving throughout life with significant morbidity. A multidisciplinary approach to NCS patients has been advocated, although a specific model is not yet established. The aim of this study was 1) to describe the organization of the recently created Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases (MOCND) at a Portuguese pediatric tertiary hospital; 2) to share our institutional experience focusing on the most common conditions, neurofibromatosis type 1 (NF1) and tuberous sclerosis complex (TSC); 3) to analyze the advantages of a multidisciplinary center and approach in NCS.Methods: Retrospective analysis of 281 patients enrolled in the MOCND over the first five years of activity (October 2016 to December 2021), reviewing genetics, family history, clinical features, complications, and therapeutic strategies for NF1 and TSC.Results: The clinic works weekly with a core team of pediatricians and pediatric neurologists supported by other specialties as needed. Of the 281 patients enrolled, 224 (79.7%) had identifiable syndromes such as NF1 (n = 105), TSC (n = 35), hypomelanosis of Ito (n = 11), Sturge-Weber syndrome (n = 5), and others. In NF1 patients, 41.0% had a positive family history, all manifested café-au-lait macules, 38.1% neurofibromas with 45.0% being large plexiformneurofibromas. Sixteen were under treatment with selumetinib. Genetic testing was performed in 82.9% of TSC patients with pathogenic variants found in TSC2 gene in 72.4% patients (82.7% if considered contiguous gene syndrome). Family history was positive in 31.4%. All TSC patients presented hypomelanotic macules and fulfilled diagnostic criteria. Fourteen patients were being treated with mTOR inhibitors.Conclusion: Offering a systematic and multidisciplinary approach to NCS patients enables timely diagnosis, promotes a structured follow-up, and encourages discussion to outline management plans for optimal care to every patient, with significant impact on the quality of life of patients and families.


  • Open Access

    Hypogonadotropic hypogonadism due to compound heterozygous mutations TACR3 in siblings

    by Rita Valsassina, Filipa Briosa, Joana Soares, Marta Amorim, Catarina Limbert

    The authors present a new association of two heterozygous TACR3 mutations (p.Arg230His and p.Trp275*) responsible for a clinical trait of normosmic congenital hypogonadotropic hypogonadism in a family.